Skip to main content (Press Enter).
Skip auxiliary navigation (Press Enter).
Terms and Conditions
Login to SNMMI Connect
Skip main navigation (Press Enter).
on this day
between these dates
PRRT Indications Guidelines: Who to Treat
Sep 5, 2019 from 2:00 PM to 3:00 PM (ET)
Objectives: Understand where 177Lutetium-dotatate might fit within the neuroendocrine tumor treatment landscape Understand impact of PRRT on key endpoints including progression-free survival and health-related quality of life Identify potential risks of 177Lutetium-dotatate, including long-term myelotoxicity Discuss relative and absolute contraindications to treatment
Download to Your Calendar
Report a Problem
Copyright 2018. All rights reserved.
Powered by Higher Logic